Pfizer to shut two manufacturing plants in India
U.S. drugmaker Pfizer Inc. said the company was shutting down two manufacturing plants in India that make generic injectables such as penicillin in response to falling demand.
Akorn gets FDA warning letter for Illinois plant
Akorn Inc. received a warning letter from the U.S. Food and Drug Administration following an inspection of the generic drugmaker’s Decatur, Illinois manufacturing plant during 2018.
Genentech Cutting More Jobs in Bay Area
South San Francisco-based Genentech filed with the State of California, indicating that the Roche company planned to cut 83 jobs.
10X Genomics Prepares to Hire 200 New Employees, Move into Larger Facility
Bay Area-based genomics company 10X Genomics has become one of the fastest growing privately held companies in the region with an earnings increase of more than 2,000 percent over a three-year period. As a result of that growth, the company optioned space in its town of Pleasanton, Calif.
Bayer Cutting More Than 200 Jobs in San Francisco Bay Area
German company Bayer AG is laying off 227 staffers at the company’s manufacturing plant in Berkeley, California. Most of the cuts took place on October 3, 2018.
With $140 Million State Incentives, Regeneron Expanding in New York and Adding 1,500 Jobs
Regeneron plans to invest more than $800 million over seven years to expand the company’s facilities in Rensselaer County, New York. This expansion is expected to create 1,500 new full-time jobs.
Boehringer Ingelheim bolsters biologics R&D
Boehringer Ingelheim announced a 230 million euro investment into a new biologicals development center at the company’s research and development site in Biberach, Germany.
Charles River Acquires Global CRO
Charles River Laboratories, a contract research organization (CRO) with headquarters in Wilmington, Mass., is buying MPI Research for about $800 million.
Homology Inks Deal for New Massachusetts HQ
Backed by financing from a collaboration with Novartis and an $83 million financing round, Homology Medicines is moving to a new facility with more than triple the space of its headquarters.
Fresenius Allegedly Ignored Hundreds of Bad Quality Tests at Plant in India
The U.S. Food and Drug Administration issued a warning letter to Fresenius Kabi AG of Germany for its plant in India.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.
February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!